Acrux Limited Announces Registry Office Relocation
Acrux Limited (AU:ACR) has announced the relocation of its registry office in Sydney, effective April 14, 2025. The new address will be Liberty Place, Level 41, 161 Castlereagh St, Sydney, managed by MUFG Corporate Markets (AU) Limited. This operational change does not affect contact details. Acrux Limited specializes in developing and commercializing topical pharmaceutical products and has a market cap of $5.39M with a year-to-date price performance of 33.33%.
Acrux Limited ( (AU:ACR) ) has issued an announcement.
Acrux Limited announced a change in the address of its registry office in Sydney, effective from April 14, 2025. The registry, managed by MUFG Corporate Markets (AU) Limited, will relocate to Liberty Place, Level 41, 161 Castlereagh St, Sydney. This change is part of the company’s ongoing operational adjustments and does not affect contact details, ensuring continuity for stakeholders.
More about Acrux Limited
Acrux Limited is a specialty pharmaceutical company with a robust history in developing and commercializing topically applied pharmaceutical products. With 25 years of experience, the company has successfully marketed products globally, particularly in the United States. Acrux focuses on formulating and developing a range of topical generic products, leveraging its skilled workforce and facilities to deliver affordable solutions. The company is open to collaboration and commercial partnerships.
YTD Price Performance: 33.33%
Average Trading Volume: 1,000
Technical Sentiment Signal: Buy
Current Market Cap: $5.39M
Learn more about ACR stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Tesla Stock Crashes: Here’s What Morgan Stanley Predicts Next
- ‘The Market Got It All Wrong,’ Says Investor About AMD Stock
- “An Affront to the First Amendment”: Paramount Stock (NASDAQ:PARA) Sinks as a Mediator is Chosen
Disclaimer & DisclosureReport an Issue
